Literature DB >> 4271409

Proceedings: A new muscle relaxant-AH8165.

C E Blogg, T M Savege, J C Simpson, L A Ross, B R Simpson.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4271409      PMCID： PMC1645634     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  14 in total

1.  The effect of circulation time on the neuromuscular action of suxamethonium.

Authors:  G A Harrison; F Junius
Journal:  Anaesth Intensive Care       Date:  1972-08       Impact factor: 1.669

2.  Diagnosis of non-depolarising block.

Authors:  S A Feldman; M Tyrrell
Journal:  Anaesthesia       Date:  1969-10       Impact factor: 6.955

3.  Effects of the inhibition of noradrenaline uptake and synthesis on the maintenance of the response to continuous nerve stimulation in the central artery of the rabbit ear.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

4.  An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study.

Authors:  B R Simpson; L Strunin; T M Savege; B Walton; E I Foley; M P Maxwell; L A Ross; D M Harris
Journal:  Lancet       Date:  1972-03-04       Impact factor: 79.321

5.  The reversal of non-depolarising relaxants. A comparison of tubocurarine, gallamine and pancuronium.

Authors:  P S Monks
Journal:  Anaesthesia       Date:  1972-07       Impact factor: 6.955

6.  Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.

Authors:  R D Miller; C P Larson; W L Way
Journal:  Anesthesiology       Date:  1972-11       Impact factor: 7.892

7.  Inhibition of succinylcholine-induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocaine.

Authors:  R D Miller; W L Way
Journal:  Anesthesiology       Date:  1971-02       Impact factor: 7.892

8.  Initial experience during the clinical use of pancuronium bromide.

Authors:  J W McIntyre; E A Gain
Journal:  Anesth Analg       Date:  1971 Sep-Oct       Impact factor: 5.108

9.  Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides.

Authors:  L Bolger; R T Brittain; D Jack; M R Jackson; L E Martin; J Mills; D Poynter; M B Tyers
Journal:  Nature       Date:  1972-08-11       Impact factor: 49.962

10.  Neuromuscular effects of d-tubocurarine, edrophonium and neostigmine in man.

Authors:  R L Katz
Journal:  Anesthesiology       Date:  1967 Mar-Apr       Impact factor: 7.892
View more
  2 in total

1.  AH 10407: a novel, short-acting, competitive neuromuscular blocking drug in animals and man.

Authors:  C E Blogg; R T Brittain; B R Simpson; M B Tyers
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  Clinical trial of fazadinium bromide (fazadon).

Authors:  C E Famewo
Journal:  Can Anaesth Soc J       Date:  1981-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.